Combined epirubicin and interleukin-2 regimen in the treatment of malignant mesothelioma: a multicenter phase II study of the Italian Group on Rare Tumors (Q77715500)
Jump to navigation
Jump to search
scientific article published on 01 September 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combined epirubicin and interleukin-2 regimen in the treatment of malignant mesothelioma: a multicenter phase II study of the Italian Group on Rare Tumors |
scientific article published on 01 September 1998 |
Statements
Combined epirubicin and interleukin-2 regimen in the treatment of malignant mesothelioma: a multicenter phase II study of the Italian Group on Rare Tumors (English)
S Bretti
A Berruti
L Dogliotti
B Castagneto
R Bertulli
P Spadaro
G Toscano
P Astorre
C Verusio
R Lionetto
P Bruzzi
1 September 1998